Each N-PORT filing of LABU compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/labu/https://themulden.com/funds/labu/148 positions became 148: 12 added (1.93% of the fund), 12 dropped (4.51%). Turnover proxy 29.7%. Largest increases: N/A 3.59% to 7.85%; Apellis Pharmaceuticals Inc 0.52% to 1.56%; Spyre Therapeutics Inc 0.23% to 0.89%; Travere Therapeutics Inc 0.7% to 1.35%; Apogee Therapeutics Inc. 0.43% to 1.06%; Summit Therapeutics Inc. 0.56% to 1.17%. Largest decreases: GOLDMAN FINANCIAL 19.73% to 6.77%; GOLDMAN SACHS LIQ ES FD A 12.91% to 1.85%; Moderna Inc 1.18% to 0.78%; GRAIL Inc 0.8% to 0.64%; Uniqure N.V. 0.5% to 0.38%; ADMA BIOLOGICS INC 0.67% to 0.57%. New: CAPRICOR THERAPEUTICS INC (0.44%), SELLAS LIFE SCIENCES GROUP INC (0.26%), ZENAS BIOPHARMA INC (0.2%), HYPERLIQUID STRATEGIES INC (0.17%), VOR BIOPHARMA INC (0.15%), VANDA PHARMACEUTICALS INC (0.14%). Gone: Amicus Therapeutics Inc. (0.94%), Avidity Biosciences Inc. (0.79%), Exact Sciences Corporation (0.79%), Arcellx Inc (0.64%), Dynavax Technologies Corp. (0.38%), RAPT Therapeutics Inc. (0.25%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 29 Jun 2026 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/131 positions became 148: 23 added (2.98% of the fund), 6 dropped (2.28%). Turnover proxy 37.7%. Largest increases: GOLDMAN FINANCIAL 8.2% to 19.73%; GOLDMAN SACHS LIQ ES FD A 7.72% to 12.91%; Mirum Pharmaceuticals Inc. 0.23% to 1.01%; Celcuity Inc. 0.06% to 0.84%; Amicus Therapeutics Inc. 0.32% to 0.94%; CG Oncology Inc. 0.25% to 0.74%. Largest decreases: N/A 36.97% to 3.59%; Avidity Biosciences Inc. 1.14% to 0.79%; Insmed Inc 0.98% to 0.64%; CRISPR Therapeutics AG 0.93% to 0.68%; Natera Inc. 0.89% to 0.77%; Viking Therapeutics Inc. 0.71% to 0.6%. New: Corvus Pharmaceuticals Inc (0.28%), RAPT Therapeutics Inc. (0.25%), Cytomx Therapeutics Inc (0.21%), Monte Rosa Therapeutics Inc (0.19%), Erasca Inc (0.18%), Kodiak Sciences Inc (0.18%). Gone: Akero Therapeutics Inc (0.69%), Metsera Inc. (0.61%), DREYFUS (0.61%), Cidara Therapeutics Inc (0.32%), Arcturus Therapeutics Holdings Inc (0.03%), aTyr Pharma Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 01 Apr 2026 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/125 positions became 131: 10 added (0.86% of the fund), 4 dropped (0.77%). Turnover proxy 31%. Largest increases: N/A 9.59% to 36.97%; Metsera Inc. 0.11% to 0.61%; Praxis Precision Medicines Inc 0.23% to 0.7%; Uniqure N.V. 0.16% to 0.53%; Avidity Biosciences Inc. 0.78% to 1.14%; Dyne Therapeutics Inc. 0.18% to 0.45%. Largest decreases: DREYFUS 4.18% to 0.61%; GOLDMAN SACHS LIQ ES FD A 10.24% to 7.72%; GOLDMAN FINANCIAL 9.89% to 8.2%; Alnylam Pharmaceuticals Inc. 2.12% to 0.73%; Halozyme Therapeutics Inc 1.8% to 0.65%; Incyte Corporation. 1.76% to 0.82%. New: Cidara Therapeutics Inc (0.32%), Sana Biotechnology Inc (0.12%), Tango Therapeutics Inc. (0.11%), Upstream Bio Inc (0.08%), Celcuity Inc. (0.06%), Rezolute Inc (0.05%). Gone: Crinetics Pharmaceuticals Inc. (0.44%), 89bio Inc. (0.2%), Humacyte Inc. (0.07%), Capricor Therapeutics Inc (0.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 29 Dec 2025 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/128 positions became 125: 5 added (0.49% of the fund), 8 dropped (2.72%). Turnover proxy 17.2%. Largest increases: GOLDMAN SACHS LIQ ES FD A 3.33% to 10.24%; N/A 5.35% to 9.59%; Halozyme Therapeutics Inc 1.1% to 1.8%; Protagonist Therapeutics Inc 0.33% to 0.73%; PTC Therapeutics, Inc. 0.46% to 0.85%; Bridgebio Pharma Inc 1.25% to 1.56%. Largest decreases: GOLDMAN FINANCIAL 17.01% to 9.89%; DREYFUS 5.58% to 4.18%; Sarepta Therapeutics Inc 0.98% to 0.41%; Natera Inc. 1.82% to 1.29%; Madrigal Pharmaceuticals Inc 1.61% to 1.25%; Exact Sciences Corporation 1.71% to 1.36%. New: Mineralys Therapeutics Inc. (0.14%), Verastem Inc (0.11%), Metsera Inc. (0.11%), Regenxbio Inc. (0.09%), Taysha Gene Therapies Inc. (0.05%). Gone: Blueprint Medicines Corporation (1.43%), Springworks Therapeutics Inc (0.83%), Rocket Pharmaceuticals Inc (0.19%), Verve Therapeutics Inc (0.1%), Prothena Corporation PLC (0.07%), Sana Biotechnology Inc (0.06%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 29 Sep 2025 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/141 positions became 128: 5 added (3.63% of the fund), 18 dropped (1.18%). Turnover proxy 12.6%. Largest increases: N/A 2.37% to 5.35%; DREYFUS 3.07% to 5.58%; GOLDMAN FINANCIAL 16.31% to 17.01%; Exelixis, Inc. 0.96% to 1.45%; Springworks Therapeutics Inc 0.63% to 0.83%; Rhythm Pharmaceuticals Inc 0.41% to 0.61%. Largest decreases: Vaxcyte Inc 1.77% to 0.76%; Sarepta Therapeutics Inc 1.66% to 0.98%; Halozyme Therapeutics Inc 1.67% to 1.1%; Neurocrine Biosciences Inc 2.16% to 1.72%; Biomarin Pharmaceutical Inc. 1.76% to 1.34%; Apellis Pharmaceuticals Inc 0.95% to 0.56%. New: GOLDMAN SACHS LIQ ES FD A (3.33%), Uniqure N.V. (0.2%), Rigel Pharmaceuticals Inc. (0.07%), Organogenesis Holdings Inc. (0.03%), Scilex Holding Co (0.01%). Gone: Avid Bioservices Inc. (0.18%), Annexon Inc (0.11%), Regenxbio Inc. (0.1%), Allogene Therapeutics Inc (0.09%), Ironwood Pharmaceuticals, Inc. (0.08%), Olema Pharmaceuticals Inc. (0.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Jun 2025 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/144 positions became 141: 8 added (0.81% of the fund), 11 dropped (0.85%). Turnover proxy 23.4%. Largest increases: GOLDMAN FINANCIAL 7.12% to 16.31%; Vaxcyte Inc 0.72% to 1.77%; Summit Therapeutics Inc. 0.21% to 0.91%; Halozyme Therapeutics Inc 0.98% to 1.67%; Bridgebio Pharma Inc 0.6% to 1.17%; TG Therapeutics Inc 0.89% to 1.43%. Largest decreases: N/A 20.98% to 2.37%; Viking Therapeutics Inc. 1.93% to 1.21%; Iovance Biotherapeutics Inc 0.71% to 0.44%; Exact Sciences Corporation 1.86% to 1.62%; Krystal Biotech Inc 0.83% to 0.59%; Incyte Corporation. 2.07% to 1.87%. New: Capricor Therapeutics Inc (0.26%), GRAIL Inc (0.23%), Tourmaline Bio Inc (0.07%), Lenz Therapeutics Inc (0.06%), Sangamo Therapeutics Inc (0.06%), Akebia Therapeutics Inc. (0.05%). Gone: Applied Therapeutics, Inc. (0.15%), Perspective Therapeutics Inc (0.13%), Sage Therapeutics Inc (0.09%), C4 Therapeutics Inc (0.08%), Ocugen Inc. (0.08%), 4D Molecular Therapeutics Inc (0.08%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 01 Apr 2025 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/140 positions became 144: 12 added (1.09% of the fund), 8 dropped (1.51%). Turnover proxy 12.1%. Largest increases: Insmed Inc 0.67% to 1.6%; Incyte Corporation. 1.52% to 2.07%; Avidity Biosciences Inc. 0.41% to 0.88%; Halozyme Therapeutics Inc 0.6% to 0.98%; Adma Biologics Inc 0.28% to 0.67%; Madrigal Pharmaceuticals Inc 0.86% to 1.21%. Largest decreases: N/A 28.63% to 20.98%; DREYFUS 3.8% to 3.16%; Regeneron Pharmaceuticals, Inc. 1.6% to 1.29%; Apellis Pharmaceuticals Inc 0.79% to 0.58%; Biomarin Pharmaceutical Inc. 1.55% to 1.38%; Cytokinetics Inc 1.28% to 1.14%. New: Applied Therapeutics, Inc. (0.15%), Emergent Biosolutions Inc (0.14%), Annexon Inc (0.14%), Perspective Therapeutics Inc (0.13%), Replimune Group Inc (0.12%), Celcuity Inc. (0.09%). Gone: Cerevel Therapeutics Holdings Inc (0.68%), Morphic Holding Inc. (0.35%), Kiniksa Pharmaceuticals International PLC (0.13%), Editas Medicine Inc (0.1%), Voyager Therapeutics Incorporation (0.07%), Heron Therapeutics Inc. (0.06%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 30 Dec 2024 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/138 positions became 140: 12 added (1.45% of the fund), 10 dropped (5.55%). Turnover proxy 39.7%. Largest increases: N/A 4.02% to 28.63%; DREYFUS 2.32% to 3.8%; Gilead Sciences, Inc. 0.78% to 1.79%; AbbVie Inc. 0.82% to 1.68%; Amgen Inc. 0.9% to 1.71%; United Therapeutics Corporation 0.87% to 1.67%. Largest decreases: GOLDMAN FINANCIAL 13.45% to 6.84%; ImmunityBio Inc 1.03% to 0.19%; PTC Therapeutics, Inc. 0.93% to 0.28%; Rhythm Pharmaceuticals Inc 0.85% to 0.29%; Ironwood Pharmaceuticals, Inc. 0.78% to 0.22%; Geron Corp. 0.93% to 0.38%. New: Janux Therapeutics Inc (0.26%), Praxis Precision Medicines Inc (0.2%), Spyre Therapeutics Inc (0.15%), Immunome Inc (0.15%), CG Oncology Inc. (0.14%), Corbus Pharmaceuticals Holdings Inc (0.11%). Gone: Alpine Immune Sciences Inc (1.49%), GOLDMAN SACHS LIQ ES FD A (1.07%), Inhibrx Inc. (0.68%), Deciphera Pharmaceuticals Inc (0.54%), Macrogenics Inc (0.51%), Biomea Fusion Inc (0.5%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 30 Sep 2024 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/124 positions became 138: 19 added (4.69% of the fund), 5 dropped (2.7%). Turnover proxy 21.3%. Largest increases: GOLDMAN FINANCIAL 10.28% to 13.45%; Alpine Immune Sciences Inc 0.2% to 1.49%; ImmunityBio Inc 0.24% to 1.03%; Geron Corp. 0.29% to 0.93%; Dyne Therapeutics Inc. 0.33% to 0.86%; Macrogenics Inc 0.13% to 0.51%. Largest decreases: N/A 12.46% to 4.02%; DREYFUS 3.48% to 2.32%; Cytokinetics Inc 1.96% to 0.84%; Biohaven Ltd 1.15% to 0.6%; Arrowhead Pharmaceuticals Inc 1.12% to 0.61%; Ardelyx Inc 1.14% to 0.66%. New: Arcutis Biotherapeutics Inc. (0.67%), Altimmune Inc. (0.57%), C4 Therapeutics Inc (0.52%), Apogee Therapeutics Inc. (0.33%), Olema Pharmaceuticals Inc. (0.29%), Fate Therapeutics Inc. (0.28%). Gone: Karuna Therapeutics Inc (1.31%), ImmunoGen, Inc. (0.86%), RAPT Therapeutics Inc. (0.22%), Uniqure N.V. (0.2%), Bluebird Bio Inc (0.13%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 28 Jun 2024 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/135 positions became 124: 6 added (13.41% of the fund), 17 dropped (6.04%). Turnover proxy 22.3%. Largest increases: Cytokinetics Inc 1.08% to 1.96%; Akero Therapeutics Inc 0.28% to 0.93%; Ardelyx Inc 0.55% to 1.14%; Sarepta Therapeutics Inc 0.63% to 1.17%; Vera Therapeutics Inc. 0.18% to 0.59%; Revolution Medicines Inc 0.57% to 0.97%. Largest decreases: GOLDMAN SACHS LIQ ES FD A 8.44% to 1.54%; Apellis Pharmaceuticals Inc 1.31% to 0.86%; Immunovant Inc 1.24% to 0.8%; GOLDMAN FINANCIAL 10.69% to 10.28%; Bluebird Bio Inc 0.48% to 0.13%; United Therapeutics Corporation 1.11% to 0.76%. New: N/A (12.46%), ImmunityBio Inc (0.24%), Soleno Therapeutics Inc (0.23%), Alpine Immune Sciences Inc (0.2%), Scholar Rock Holding Corp. (0.14%), Macrogenics Inc (0.13%). Gone: Mirati Therapeutics Inc (1.75%), Seagen Inc (1.17%), Intercept Pharmaceuticals Inc (0.73%), Coherus Biosciences Inc (0.37%), POINT Biopharma Global Inc. (0.36%), Allogene Therapeutics Inc (0.28%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 01 Apr 2024 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/141 positions became 135: 7 added (1.69% of the fund), 13 dropped (13.17%). Turnover proxy 25.6%. Largest increases: GOLDMAN SACHS LIQ ES FD A 1.45% to 8.44%; GOLDMAN FINANCIAL 6.88% to 10.69%; DREYFUS 2.28% to 3.49%; Apellis Pharmaceuticals Inc 0.25% to 1.31%; Mirati Therapeutics Inc 0.7% to 1.75%; Biohaven Ltd 0.4% to 1.15%. Largest decreases: Bridgebio Pharma Inc 1.93% to 1.03%; Travere Therapeutics Inc 0.91% to 0.3%; Relay Therapeutics Inc 0.84% to 0.31%; Arcutis Biotherapeutics Inc. 0.58% to 0.12%; Akero Therapeutics Inc 0.73% to 0.28%; Morphic Holding Inc. 0.78% to 0.35%. New: Coherus Biosciences Inc (0.37%), Disc Medicine Inc (0.36%), Caribou Biosciences Inc (0.23%), Acelyrin Inc (0.22%), Cabaletta Bio Inc (0.21%), Vera Therapeutics Inc. (0.18%). Gone: N/A (9.49%), Horizon Therapeutics PLC (0.89%), Chinook Therapeutics Inc (0.86%), Emergent Biosolutions Inc (0.42%), Fate Therapeutics Inc. (0.42%), Allakos Inc (0.2%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 02 Jan 2024 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/150 positions became 141: 5 added (4.42% of the fund), 14 dropped (7.77%). Turnover proxy 20.6%. Largest increases: N/A 3.35% to 9.49%; Bridgebio Pharma Inc 0.44% to 1.93%; Halozyme Therapeutics Inc 0.6% to 1.11%; Morphic Holding Inc. 0.32% to 0.78%; Twist Bioscience Corporation 0.61% to 1.07%; Chinook Therapeutics Inc 0.41% to 0.86%. Largest decreases: GOLDMAN FINANCIAL 10.32% to 6.88%; Apellis Pharmaceuticals Inc 1.04% to 0.25%; Viking Therapeutics Inc. 1.31% to 0.53%; TG Therapeutics Inc 1.36% to 0.66%; Fate Therapeutics Inc. 0.96% to 0.42%; Sage Therapeutics Inc 0.92% to 0.51%. New: DREYFUS (2.28%), GOLDMAN SACHS LIQ ES FD A (1.45%), Biomea Fusion Inc (0.32%), Aldeyra Therapeutics Inc (0.22%), Dyne Therapeutics Inc. (0.15%). Gone: DREYFUS (2.89%), Prometheus Biosciences Inc. (1.31%), Iveric Bio Inc. (1.18%), CTI BioPharma Corp. (0.63%), Karyopharm Therapeutics Inc (0.37%), Coherus Biosciences Inc (0.33%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 Sep 2023 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/156 positions became 150: 5 added (3.03% of the fund), 11 dropped (2.56%). Turnover proxy 27.4%. Largest increases: GOLDMAN FINANCIAL 4.89% to 10.32%; Fate Therapeutics Inc. 0.19% to 0.96%; Prometheus Biosciences Inc. 0.62% to 1.31%; Roivant Sciences Ltd 0.16% to 0.72%; Arcus Biosciences Inc. 0.32% to 0.83%; Novavax Inc 0.4% to 0.91%. Largest decreases: N/A 17.75% to 3.35%; DREYFUS 9.73% to 2.89%; Madrigal Pharmaceuticals Inc 2.28% to 1%; Altimmune Inc. 0.61% to 0.3%; Relay Therapeutics Inc 0.76% to 0.57%; Caredx Inc 0.55% to 0.37%. New: Viking Therapeutics Inc. (1.31%), Ardelyx Inc (0.78%), 89bio Inc. (0.58%), BioXcel Therapeutics Inc. (0.35%), MiNK Therapeutics Inc. (0.01%). Gone: Myovant Sciences Ltd (0.56%), Gossamer Bio Inc (0.55%), Sorrento Therapeutics Inc (0.31%), Ocugen Inc. (0.24%), PMV Pharmaceuticals Inc (0.16%), Eagle Pharmaceuticals Inc (0.15%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 29 Jun 2023 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/155 positions became 156: 10 added (11.89% of the fund), 9 dropped (11.4%). Turnover proxy 20.7%. Largest increases: Madrigal Pharmaceuticals Inc 0.51% to 2.28%; N/A 17.2% to 17.75%; Biohaven Ltd 0.04% to 0.52%; GOLDMAN FINANCIAL 4.51% to 4.89%; TG Therapeutics Inc 0.49% to 0.86%; Avidity Biosciences Inc. 0.1% to 0.43%. Largest decreases: Biogen Inc 1% to 0.63%; Fate Therapeutics Inc. 0.56% to 0.19%; Gilead Sciences, Inc. 0.9% to 0.58%; Celldex Therapeutics Inc. 0.79% to 0.47%; Halozyme Therapeutics Inc 0.87% to 0.55%; Arcus Biosciences Inc. 0.63% to 0.32%. New: DREYFUS (9.73%), Akero Therapeutics Inc (0.7%), Scilex Holding Co (0.47%), Immunovant Inc (0.31%), Allakos Inc (0.18%), Roivant Sciences Ltd (0.16%). Gone: ACM GOV'T PORT. #27 (7.3%), N/A (2.86%), Ligand Pharmaceuticals Incorporated (0.34%), Heron Therapeutics Inc. (0.25%), Nkarta Inc. (0.22%), Vaxart Inc. (0.19%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 31 Mar 2023 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/138 positions became 155: 27 added (7% of the fund), 10 dropped (3.23%). Turnover proxy 19.1%. Largest increases: ACM GOV'T PORT. #27 5.54% to 7.3%; Iveric Bio Inc. 0.56% to 0.97%; Biogen Inc 0.62% to 1%; Gilead Sciences, Inc. 0.56% to 0.9%; Prothena Corporation PLC 0.38% to 0.71%; Mannkind Corporation 0.21% to 0.53%. Largest decreases: N/A 22.28% to 17.2%; GOLDMAN FINANCIAL 8.35% to 4.51%; N/A 4.68% to 2.86%; Beam Therapeutics Incorporation 1.08% to 0.57%; Twist Bioscience Corporation 0.93% to 0.56%; Fate Therapeutics Inc. 0.87% to 0.56%. New: Verve Therapeutics Inc (0.73%), Rhythm Pharmaceuticals Inc (0.71%), Bluebird Bio Inc (0.66%), Prometheus Biosciences Inc. (0.54%), Inhibrx Inc. (0.46%), Altimmune Inc. (0.41%). Gone: Global Blood Therapeutics Incorporation (0.82%), Biohaven Pharmaceutical Holding Company Limited (0.57%), Chemocentryx Inc (0.53%), Turning Point Therapeutics Inc (0.41%), Rigel Pharmaceuticals Inc. (0.19%), Organogenesis Holdings Inc. (0.19%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 27 Dec 2022 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/159 positions became 138: 6 added (6.94% of the fund), 27 dropped (4.56%). Turnover proxy 36.8%. Largest increases: N/A 2.33% to 22.28%; N/A 1.77% to 4.68%; Beam Therapeutics Incorporation 0.4% to 1.08%; Twist Bioscience Corporation 0.42% to 0.93%; Novavax Inc 0.4% to 0.76%; Intellia Therapeutics Inc 0.51% to 0.86%. Largest decreases: GOLDMAN FINANCIAL 34.52% to 8.35%; Karyopharm Therapeutics Inc 0.59% to 0.29%; Turning Point Therapeutics Inc 0.68% to 0.41%; Arcturus Therapeutics Holdings Inc 0.55% to 0.31%; Alkermes PLC 0.76% to 0.53%; Deciphera Pharmaceuticals Inc 0.51% to 0.29%. New: ACM GOV'T PORT. #27 (5.54%), CRISPR Therapeutics AG (0.67%), CTI BioPharma Corp. (0.42%), EQRx Inc. (0.15%), Nkarta Inc. (0.09%), POINT Biopharma Global Inc. (0.06%). Gone: OPKO Health, Inc. (0.53%), Bluebird Bio Inc (0.43%), Verve Therapeutics Inc (0.33%), ALX Oncology Holdings Inc (0.24%), DermTech Inc. (0.23%), ImmunityBio Inc (0.2%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 29 Sep 2022 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/189 positions became 159: 3 added (4.25% of the fund), 33 dropped (5.75%). Turnover proxy 11.4%. Largest increases: Bridgebio Pharma Inc 0.16% to 0.6%; Sana Biotechnology Inc 0.2% to 0.44%; ImmunoGen, Inc. 0.27% to 0.5%; Moderna Inc 0.4% to 0.63%; OPKO Health, Inc. 0.31% to 0.53%; Krystal Biotech Inc 0.22% to 0.44%. Largest decreases: BioCryst Pharmaceuticals Inc. 0.8% to 0.37%; Protagonist Therapeutics Inc 0.56% to 0.23%; Biohaven Pharmaceutical Holding Company Limited 0.81% to 0.48%; Agenus Inc. 0.52% to 0.26%; G1 Therapeutics Inc. 0.4% to 0.16%; Myriad Genetics Inc. 0.53% to 0.32%. New: N/A (2.33%), N/A (1.77%), Prometheus Biosciences Inc. (0.14%). Gone: Arena Pharmaceuticals Inc. (1.11%), Kodiak Sciences Inc (0.43%), Invitae Corporation (0.42%), Recursion Pharmaceuticals Inc (0.38%), Altimmune Inc (0.34%), Clovis Oncology Inc (0.31%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 29 Jun 2022 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/188 positions became 189: 14 added (2.29% of the fund), 13 dropped (3.78%). Turnover proxy 20.5%. Largest increases: GOLDMAN FINANCIAL 19.82% to 34.63%; Arena Pharmaceuticals Inc. 0.59% to 1.11%; Turning Point Therapeutics Inc 0.32% to 0.57%; BioCryst Pharmaceuticals Inc. 0.6% to 0.8%; Emergent Biosolutions Inc 0.51% to 0.71%; Biohaven Pharmaceutical Holding Company Limited 0.65% to 0.81%. Largest decreases: Chemocentryx Inc 1.39% to 0.48%; Ocugen Inc 1.02% to 0.4%; Allakos Inc 0.59% to 0.06%; Bridgebio Pharma Inc 0.6% to 0.16%; OPKO Health, Inc. 0.63% to 0.31%; Kodiak Sciences Inc 0.75% to 0.43%. New: Verve Therapeutics Inc (0.47%), 2Seventy Bio Inc (0.39%), Rapt Therapeutics Incorporation (0.21%), Gritstone Bio Inc (0.17%), iTeos Therapeutics Inc (0.16%), 4D Molecular Therapeutics Inc (0.14%). Gone: Acceleron Pharma Inc (0.81%), Humanigen Inc (0.64%), Dicerna Pharmaceuticals Inc (0.59%), Kadmon Hldgs Inc (0.47%), Spectrum Pharmaceuticals Inc (0.25%), Applied Molecular Transport Inc (0.21%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 01 Apr 2022 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/196 positions became 188: 6 added (0.83% of the fund), 14 dropped (3.51%). Turnover proxy 15.8%. Largest increases: GOLDMAN FINANCIAL 13.95% to 19.82%; Chemocentryx Inc 0.72% to 1.39%; Cerevel Therapeutics Holdings Inc 0.24% to 0.66%; Iveric Bio Inc 0.19% to 0.6%; Global Blood Therapeutics Incorporation 0.4% to 0.8%; Seres Therapeutics 0.21% to 0.59%. Largest decreases: Moderna Inc 0.96% to 0.47%; Intellia Therapeutics Inc 0.99% to 0.51%; Cortexyme Inc 0.47% to 0.07%; Editas Medicine Inc 0.67% to 0.34%; Scholar Rock Holding Corporation 0.5% to 0.19%; Celldex Therapeuti 0.79% to 0.48%. New: Recursion Pharmaceuticals Inc (0.26%), Crinetics Pharmaceuticals Inc (0.14%), Ideaya Biosciences Inc (0.13%), Vistagen Therapeutics Inc (0.11%), Selecta Biosciences, Inc. (0.11%), Lineage Cell Therapeutics Incorporation (0.09%). Gone: Translate Bio, Inc. (0.77%), Sesen Bio Inc (0.52%), Athenex Incorporation (0.35%), Esperion Therapeutics Inc (0.35%), Flexion Therapeutics Inc (0.24%), Adverum Biotechnologies Inc (0.23%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 28 Dec 2021 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/192 positions became 196: 13 added (4.85% of the fund), 9 dropped (3.46%). Turnover proxy 15.4%. Largest increases: GOLDMAN FINANCIAL 10.18% to 13.95%; Anavex Life Scienc 0.26% to 0.69%; Intellia Therapeutics Inc 0.71% to 0.99%; Kymera Therapeutics Inc 0.43% to 0.71%; Scholar Rock Holding Corporation 0.29% to 0.5%; Chemocentryx Inc 0.51% to 0.72%. Largest decreases: Vaxart Inc 0.97% to 0.49%; CEL Sci Corp 0.63% to 0.22%; Seres Therapeutics 0.59% to 0.21%; Sage Therapeutics Inc 0.61% to 0.33%; Humanigen Inc 0.72% to 0.46%; Vericel Corporation 0.81% to 0.55%. New: Horizon Therapeutics Plc (0.64%), Organogenesis Holdings Inc. (0.61%), Myovant Sciences Ltd (0.54%), Sesen Bio Inc (0.52%), Avid Bioservices Inc (0.48%), Rubius Therapeutics Inc (0.46%). Gone: N/A (1.13%), Alexion Pharmaceuticals, Inc. (0.67%), Black Diamond Therapeutics Inc (0.49%), Constellation Pharmaceuticals Inc. (0.44%), Praxis Precision Medicines Inc (0.21%), Athersys Inc (0.19%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 27 Sep 2021 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/171 positions became 192: 24 added (7.91% of the fund), 3 dropped (0.29%). Turnover proxy 47.4%. Largest increases: Zentalis Pharmaceuticals Inc 0.09% to 0.71%; Mannkind Corporation 0.1% to 0.7%; Generation Bio Co 0.05% to 0.63%; Vericel Corporation 0.3% to 0.81%; Dicerna Pharmaceuticals Inc 0.19% to 0.68%; Macrogenics Inc 0.17% to 0.65%. Largest decreases: N/A 28.18% to 1.13%; GOLDMAN FINANCIAL 29.72% to 10.18%; Ligand Pharmaceuticals Incorporated 0.7% to 0.54%; VIR Biotechnology Inc 0.71% to 0.55%; Sorrento Therapeutics Inc 0.57% to 0.49%; Emergent Biosolutions Inc 0.45% to 0.41%. New: Ocugen Inc (0.77%), Humanigen Inc (0.72%), Curis Inc (0.6%), Altimmune Inc (0.52%), Sutro Biopharma Inc (0.51%), Dermtech Inc (0.48%). Gone: Cardiff Oncology Inc (0.17%), Viela Bio Inc (0.09%), Five Prime Therapeutics (0.04%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Jun 2021 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/141 positions became 171: 38 added (5.29% of the fund), 8 dropped (19.82%). Turnover proxy 27.2%. Largest increases: GOLDMAN FINANCIAL 11.58% to 29.72%; Ligand Pharmaceuticals Incorporated 0.31% to 0.7%; Novavax Inc 0.32% to 0.62%; Clovis Oncology Inc 0.31% to 0.57%; Intercept Pharmaceuticals Inc 0.26% to 0.4%; Revolution Medicines Inc 0.11% to 0.26%. Largest decreases: N/A 28.83% to 28.18%; Mirati Therapeutics Inc 0.63% to 0.3%; Arcturus Therapeutics Holdings Inc 0.54% to 0.24%; Arrowhead Pharmaceuticals Inc 0.66% to 0.37%; Blueprint Medicines Corporation 0.59% to 0.3%; EXACT SCIENCES CORPORATION 0.62% to 0.37%. New: VIR Biotechnology Inc (0.71%), Vaxart Inc (0.57%), Beam Therapeutics Incorporation (0.39%), Seres Therapeutics (0.34%), Replimune Group Inc (0.25%), Celldex Therapeuti (0.21%). Gone: DREYFUS GOVERNMENT CASH MANAGEMENT (19.34%), Retrophin Inc (0.16%), Corbus Pharmaceuticals Holdings Inc (0.11%), Assembly Biosciences Inc (0.07%), Prothena Corp Plc (0.05%), Syros Pharmaceuticals Inc (0.04%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 31 Mar 2021 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/134 positions became 141: 14 added (21.62% of the fund), 7 dropped (2.77%). Turnover proxy 24.4%. Largest increases: N/A 28.16% to 28.83%; Translate Bio, Inc. 0.13% to 0.38%; Kodiak Sciences Inc 0.29% to 0.48%; INTELLIA THERAPEUTICS INC 0.23% to 0.38%; Mersana Therapeutics Inc 0.12% to 0.27%; Turning Point Therapeutics Inc 0.32% to 0.45%. Largest decreases: GOLDMAN FINANCIAL 22.2% to 11.58%; Novavax Inc 1.58% to 0.32%; OPKO Health, Inc. 1.05% to 0.45%; Emergent Biosolutions Inc 0.82% to 0.35%; Invitae Corporation 0.91% to 0.46%; Inovio Biomedical 0.75% to 0.38%. New: DREYFUS GOVERNMENT CASH MANAGEMENT (19.34%), Arcturus Therapeutics Holdings Inc (0.54%), Seagen Inc (0.43%), VBI Vaccines Inc CDA (0.29%), Springworks Therapeutics Inc (0.19%), Immunovant Inc (0.18%). Gone: Immunomedics Inc (0.69%), Seattle Genetics I (0.55%), Principia Biopharma Inc (0.52%), Momenta Pharmaceut (0.48%), Aimmune Therapeutics Incorporation (0.35%), Homology Medicines Inc (0.1%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Dec 2020 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/123 positions became 134: 18 added (5.03% of the fund), 7 dropped (0.62%). Turnover proxy 26.7%. Largest increases: N/A 16.8% to 28.16%; OPKO Health, Inc. 0.23% to 1.05%; Bridgebio Pharma Inc 0.12% to 0.49%; Twist Bioscience Corporation 0.15% to 0.52%; Biocryst Pharmactl 0.11% to 0.48%; TG Therapeutics Inc 0.22% to 0.57%. Largest decreases: GOLDMAN FINANCIAL 39.41% to 22.2%; Moderna Inc 1.5% to 0.6%; EXELIXIS, INC. 1.09% to 0.52%; Regeneron Pharmaceuticals, Inc. 1.11% to 0.54%; Gilead Sciences, Inc. 1.01% to 0.48%; United Therapeutics Corporation 0.95% to 0.49%. New: Novavax Inc (1.58%), Inovio Biomedical (0.75%), Sorrento Therapeutics Inc (0.57%), Bioxcel Therapeutics INC (0.33%), CEL Sci Corp (0.22%), Constellation Pharmaceuticals Inc. (0.22%). Gone: Portola Pharmaceuticals Inc (0.13%), Amag Pharmaceutical Inc (0.12%), Precigen Inc (0.08%), Progenics Pharmace (0.08%), Akcea Therapeutics Inc (0.07%), Stemline Therapeutics Inc (0.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 25 Sep 2020 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/124 positions became 123: 1 added (0.08% of the fund), 2 dropped (0.95%). Turnover proxy 27.4%. Largest increases: GOLDMAN FINANCIAL 20.95% to 39.41%; N/A 8.35% to 16.8%; Moderna Inc 1.12% to 1.5%. Largest decreases: Sage Therapeutics Inc 1.2% to 0.42%; Bluebird Bio Inc 1.17% to 0.47%; EXACT SCIENCES CORPORATION 1.41% to 0.71%; Invitae Corporation 1.42% to 0.75%; Myriad Genetics In 0.79% to 0.27%; Ionis Pharmaceuticals, Inc. 1.22% to 0.69%. New: Precigen Inc (0.08%). Gone: Ra Pharmaceuticals Inc (0.77%), Intrexon Corporation (0.18%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 25 Jun 2020 12:00:00 GMThttps://themulden.com/funds/labu/https://themulden.com/funds/labu/119 positions became 124: 14 added (3.5% of the fund), 9 dropped (7.45%). Turnover proxy 17.3%. Largest increases: N/A 2.62% to 8.35%; APELLIS PHARMACEUTICALS INC 0.33% to 0.97%; Invitae Corporation 0.9% to 1.42%; Acceleron Pharma Inc 0.42% to 0.84%; EXACT SCIENCES CORPORATION 0.98% to 1.41%; Deciphera Pharmaceuticals Inc 0.33% to 0.7%. Largest decreases: GOLDMAN FINANCIAL 23.24% to 20.95%; Arrowhead Pharmaceuticals Inc 1.62% to 0.83%; Seattle Genetics I 1.84% to 1.25%; Portola Pharmaceuticals Inc 0.91% to 0.38%; Biogen Inc 1.52% to 1.19%; Mirati Therapeutics Inc 1.33% to 1.02%. New: Moderna Inc (1.12%), Clovis Oncology Inc (0.4%), Alector Inc (0.25%), Principia Biopharma Inc (0.24%), Bridgebio Pharma Inc (0.22%), Kodiak Sciences Inc (0.2%). Gone: The Medicines Company (1.33%), Celgene Corporation (1.33%), Spark Therapeutics Inc (1.26%), Repligen Corporation (1.2%), Genomic Health Inc (0.88%), Arqule Inc (0.76%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 30 Mar 2020 12:00:00 GMT